{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:11:31Z","timestamp":1772817091285,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2001,11,1]]},"DOI":"10.2174\/1381612013397177","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T01:10:31Z","timestamp":1111713031000},"source":"Crossref","is-referenced-by-count":13,"title":["Rationally Designed Anti-mitotic Agents with Pro-Apoptotic Activity"],"prefix":"10.2174","volume":"7","author":[{"given":"Fatih M.","family":"Uckun","sequence":"first","affiliation":[{"name":"Drug Discovery Program,Parker Hughes Cancer Center, Parker Hughes Institute, 2665 Long Lake Road, St. Paul, Minnesota 55113."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/65131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T14:22:13Z","timestamp":1503584533000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/65131\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":0,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2001,11,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612013397177","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}